4-
Sponsors
Bio-innova and Synchron.Co.,Ltd, Department of Thai Traditional and Alternative Medicine, Ministry Of Public Health, none, Institutional Review Boards in Mahidol University
Conditions
Bioequivalence study
Bioequivalence
TamsulosinBioequivalence study in healthy volunteers
Bioequivalence
Losartan
HydrochlorothiazideConstipation
Constipation
MassageInfection complication
Graft thrombosispost operatiev vomiting in preschool children
postoperative nausea and vomiting
laparoscopic surgery
liberal fluid therapy
pediatric anesthesia
Phase 1
A Bioequivalence study of a randomized, open-label, 4-period, 2-treatment, 2-sequence, replicate, crossover study of Losartan 100 mg + Hydrochlorothiazide 25 mg tablets relative to Fortzaar® 100/25 mg tablets in healthy Thai volunteers under fasting condition
Active, not recruitingTCTR20170629005
Start: 2017-09-01Target: 40Updated: 2026-03-30
A Bioequivalence study of a randomized, open-label, fully replicate crossover design with four-period, two-treatment and two-sequence of Tamsulosin Hydrochloride, 0.4 mg prolonged release tablets relative to Harnal OCAS® 0.4 mg tablets in healthy Thai male volunteers under fasting condition
Active, not recruitingTCTR20181204002
Start: 2019-02-01Target: 32Updated: 2026-03-30